No Data
No Data
Novo Nordisk (NVO) Stock Declines While Market Improves: Some Information for Investors
Obesity Drugs Seen Costing Medicare $35 Billion Through 2034
Express News | Obesity Drug Coverage Could Boost Spending By $35B Through 2034
WeightWatchers Is Offering Knockoff Wegovy. The Market Is Already Crowded. -- Barrons.com
Novo Nordisk Advances Share Buyback Program
Eli Lilly Obesity Drug Shortage Ends Fueling Lawsuit Against FDA
No Data
No Data
夜轻歌 : I disagree with your NVO put
约翰の理财库 OP 夜轻歌 : Is not a Buy Put, is a Sell Put with buying back to closing the position in profit. Let me show you the 7days transaction instead of 2days transaction
约翰の理财库 OP 约翰の理财库 OP : I Sold at $46 and Buy back at $8 , so the profit is $38 x 28position = $1064 profit sealed . With now no more NVO position in hand after closing
夜轻歌 约翰の理财库 OP : Thank you for your reply. I got it.
夜轻歌 约翰の理财库 OP : Thanks for your sharing.
View more comments...